Company Filing History:
Years Active: 2006-2008
Title: Innovations of Keith McCormack
Introduction
Keith McCormack is a notable inventor based in Kilburn, GB. He has made significant contributions to the field of analgesic compositions, particularly through his innovative patents. With a total of two patents to his name, McCormack's work focuses on enhancing pain relief methods.
Latest Patents
McCormack's latest patents include formulations that utilize buprenorphine in unique ways. One of his key inventions is an analgesic composition in parenteral unit dosage form or in a unit dosage form suitable for delivery via the mucosa. This composition contains an amount of buprenorphine that is less than the clinical dose required to achieve pain relief. Additionally, it includes naloxone, with the ratio by weight of buprenorphine to naloxone ranging from 12.5:1 to 27.5:1. Alternatively, it can contain naltrexone or nalmefene, with the ratio by weight of buprenorphine to these substances ranging from 12.5:1 to 22.5:1. The analgesic action of buprenorphine is potentiated by the low dose of naloxone, naltrexone, or nalmefene.
Career Highlights
McCormack is currently associated with Reckitt Benckiser Healthcare (UK) Limited, where he continues to innovate in the healthcare sector. His work has been instrumental in developing new pain management solutions that are both effective and safe for patients.
Collaborations
Some of McCormack's notable coworkers include Christopher Bourne Chapleo and Nicolas Calvert Varey. Their collaborative efforts contribute to the advancement of healthcare innovations.
Conclusion
Keith McCormack's contributions to analgesic compositions highlight his role as a significant inventor in the healthcare industry. His innovative approaches to pain relief continue to impact the field positively.